New aspects on efficient anticoagulation and antiplatelet strategies in sheep

[1]  J. Mega,et al.  Clinical Pharmacogenetics Implementation Consortium Guidelines for CYP2C19 Genotype and Clopidogrel Therapy: 2013 Update , 2013, Clinical pharmacology and therapeutics.

[2]  Ulrich Kneser,et al.  Engineering axially vascularized bone in the sheep arteriovenous‐loop model , 2013, Journal of tissue engineering and regenerative medicine.

[3]  A. Schmaier,et al.  Recommendations for the standardization of light transmission aggregometry: a consensus of the working party from the platelet physiology subcommittee of SSC/ISTH , 2013, Journal of thrombosis and haemostasis : JTH.

[4]  Jillian E. Beveridge,et al.  Osteoarthritis develops in the operated joint of an ovine model following ACL reconstruction with immediate anatomic reattachment of the native ACL , 2013, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[5]  E. Monti,et al.  Rhabdomyosarcomas: an overview on the experimental animal models , 2012, Journal of cellular and molecular medicine.

[6]  M. Longaker,et al.  Large animal induced pluripotent stem cells as pre-clinical models for studying human disease , 2012, Journal of cellular and molecular medicine.

[7]  Matthew T. Lahti,et al.  Dabigatran versus Warfarin after Mechanical Mitral Valve Replacement in the Swine Model , 2012, Journal of investigative surgery : the official journal of the Academy of Surgical Research.

[8]  C. Gachet.  P2Y12 receptors in platelets and other hematopoietic and non-hematopoietic cells , 2012, Purinergic Signalling.

[9]  B. Jena,et al.  Water channels in platelet volume regulation , 2012, Journal of cellular and molecular medicine.

[10]  Andreas Clemens,et al.  Switching from enoxaparin to dabigatran etexilate: pharmacokinetics, pharmacodynamics, and safety profile , 2012, European Journal of Clinical Pharmacology.

[11]  O. Reinhartz,et al.  Challenges in Longer-Term Mechanical Support of Fontan Circulation in Sheep , 2012, ASAIO journal.

[12]  D. Arens,et al.  Double-plating of ovine critical sized defects of the tibia: a low morbidity model enabling continuous in vivo monitoring of bone healing , 2011, BMC musculoskeletal disorders.

[13]  K. Sangkuhl,et al.  Clinical Pharmacogenetics Implementation Consortium Guidelines for Cytochrome P450–2C19 (CYP2C19) Genotype and Clopidogrel Therapy , 2011, Clinical pharmacology and therapeutics.

[14]  B. David,et al.  Survival and function of mesenchymal stem cells (MSCs) depend on glucose to overcome exposure to long-term, severe and continuous hypoxia , 2011, Journal of cellular and molecular medicine.

[15]  M. Gheorghe,et al.  Development and validation of an HPLC–MS/MS method to quantify clopidogrel acyl glucuronide, clopidogrel acid metabolite, and clopidogrel in plasma samples avoiding analyte back-conversion , 2011, Analytical and bioanalytical chemistry.

[16]  G. Hankey,et al.  Dabigatran Etexilate: A New Oral Thrombin Inhibitor , 2011, Circulation.

[17]  A. Boos,et al.  Directly auto-transplanted mesenchymal stem cells induce bone formation in a ceramic bone substitute in an ectopic sheep model , 2010, Journal of cellular and molecular medicine.

[18]  A. Hnatiuk,et al.  Reference values for echocardiographic parameters and indexes of left ventricular function in healthy, young adult sheep used in translational research: comparison with standardized values in humans. , 2011, International journal of clinical and experimental medicine.

[19]  G. Montalescot,et al.  Cardiovascular risk in clopidogrel-treated patients according to cytochrome P450 2C19*2 loss-of-function allele or proton pump inhibitor coadministration: a systematic meta-analysis. , 2010, Journal of the American College of Cardiology.

[20]  Ville Ellä,et al.  Fibrin-polylactide-based tissue-engineered vascular graft in the arterial circulation. , 2010, Biomaterials.

[21]  Andreas Hess,et al.  Axial vascularization of a large volume calcium phosphate ceramic bone substitute in the sheep AV loop model , 2010, Journal of tissue engineering and regenerative medicine.

[22]  P. Monagle,et al.  The in vitro response to low-molecular-weight heparin is not age-dependent in children , 2010, Thrombosis and Haemostasis.

[23]  H. Diener,et al.  Antiplatelet therapy in secondary stroke prevention – state of the art , 2010, Journal of cellular and molecular medicine.

[24]  M. Wilhelmi,et al.  Measurement of platelet aggregation in ovine blood using a new impedance aggregometer. , 2009, Veterinary clinical pathology.

[25]  S. Husted,et al.  Ticagrelor: The First Reversibly Binding Oral P2Y12 Receptor Antagonist , 2009, Cardiovascular therapeutics.

[26]  Rakesh K. Sharma,et al.  Aspirin and clopidogrel hyporesponsiveness and nonresponsiveness in patients with coronary artery stenting , 2009, Vascular health and risk management.

[27]  Y. Jeong,et al.  Randomized comparison of adjunctive cilostazol versus high maintenance dose clopidogrel in patients with high post-treatment platelet reactivity: results of the ACCEL-RESISTANCE (Adjunctive Cilostazol Versus High Maintenance Dose Clopidogrel in Patients With Clopidogrel Resistance) randomized study. , 2009, Journal of the American College of Cardiology.

[28]  S. Kuhle,et al.  Evaluation of enoxaparin dosing requirements in infants and children , 2008, Thrombosis and Haemostasis.

[29]  L. Monreal,et al.  Poor reproducibility of template bleeding time in horses. , 2008, Journal of veterinary internal medicine.

[30]  W. Wienen,et al.  Dabigatran Inhibits Both Clot-Bound and Fluid Phase Thrombin In Vitro: Effects Compared to Heparin and Hirudin. , 2007 .

[31]  J. Stassen,et al.  Antithrombotic and anticoagulant effects of the direct thrombin inhibitor dabigatran, and its oral prodrug, dabigatran etexilate, in a rabbit model of venous thrombosis , 2007, Journal of thrombosis and haemostasis : JTH.

[32]  J. Connell,et al.  Anticoagulation of Juvenile Sheep and Goats With Heparin, Warfarin, and Clopidogrel , 2007, ASAIO journal.

[33]  Paul J. Harrison,et al.  Measuring antiplatelet drug effects in the laboratory. , 2007, Thrombosis research.

[34]  K. Bairy,et al.  Aspirin resistance. , 2007, Indian journal of physiology and pharmacology.

[35]  S. Gay,et al.  Comparative investigation on the influence of human bovine collagen types I, II and III on the aggregation of human platelets , 1975, Klinische Wochenschrift.

[36]  Hu Hu,et al.  Influence of extracellular calcium on single platelet activation as measured by whole blood flow cytometry. , 2005, Thrombosis research.

[37]  杨靓,et al.  Aspirin resistance , 2004 .

[38]  P. Gentry,et al.  Ovine platelet function and its inhibition by T-2 toxin , 2004, Veterinary Research Communications.

[39]  B. Min,et al.  Heparin monitoring in sheep by activated partial thromboplastin time. , 2003, Artificial organs.

[40]  P. Lombardi,et al.  Adhesive properties of platelets from different animal species. , 2003, Journal of comparative pathology.

[41]  P. Lombardi,et al.  Species variability in platelet aggregation response to different agonists. , 2002, Journal of comparative pathology.

[42]  P. Anzenbacher,et al.  Cytochromes P450 and experimental models of drug metabolism , 2002, Journal of cellular and molecular medicine.

[43]  J. Spivak,et al.  Commentary on and reprint of Born GVR, Aggregation of blood platelets by adenosine diphosphate and its reversal, in Nature (1962) 194:927–929 , 2000 .

[44]  J. Reul,et al.  Zur Übertragbarkeit tierexperimenteller endovaskulärer Studien : Unterschiede der Gerinnungs- und Fibrinolyse-Systeme bei häufig verwendeten Tierspezies im Vergleich zum Menschen , 2000 .

[45]  S. Goodman,et al.  Sheep, pig, and human platelet-material interactions with model cardiovascular biomaterials. , 1999, Journal of biomedical materials research.

[46]  W. Hawthorne,et al.  Suppression of intimal hyperplasia with low molecular weight heparin in a sheep model. , 1999, International angiology : a journal of the International Union of Angiology.

[47]  B. Griffith,et al.  In Vivo Evaluation of an Extracorporeal Pediatric Centrifugal Blood Pump , 1996, ASAIO journal.

[48]  J. Fletcher,et al.  Inhibition of fibro-intimal hyperplasia in a polytetrafluoroethylene vascular graft with standard heparin and low molecular weight heparin. , 1996, The Australian and New Zealand journal of surgery.

[49]  P. Bath,et al.  Platelet size: measurement, physiology and vascular disease. , 1996, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

[50]  J. Sixma,et al.  Platelet adhesion to collagen types I through VIII under conditions of stasis and flow is mediated by GPIa/IIa (alpha 2 beta 1-integrin). , 1994, Blood.

[51]  H. Spanos.  Aspirin fails to inhibit platelet aggregation in sheep. , 1993, Thrombosis research.

[52]  F. Ofosu,et al.  The comparison of the pharmacokinetics of a low molecular weight heparin in the newborn and adult pig. , 1989, Thrombosis research.

[53]  A. M. Lefer,et al.  Responsiveness of platelets and coronary arteries from different species to synthetic thromboxane and prostaglandin endoperoxide analogues , 1983, British journal of pharmacology.

[54]  P. Majerus,et al.  Inhibition of platelet prostaglandin synthetase by oral aspirin. , 1978, The Journal of clinical investigation.

[55]  P. Majerus,et al.  Comparative effects of aspirin and diflunisal on prostaglandin synthetase from human platelets and sheep seminal vesicles. , 1977, British journal of clinical pharmacology.

[56]  J. D. Baggot,et al.  Pharmacokinetics and dosage of aspirin in cattle. , 1975, Journal of the American Veterinary Medical Association.

[57]  G J Roth,et al.  Acetylation of prostaglandin synthase by aspirin. , 1975, Proceedings of the National Academy of Sciences of the United States of America.

[58]  Davis Le,et al.  Species differences in biotransformation and excretion of salicylate. , 1972 .

[59]  L. E. Davis,et al.  Species differences in biotransformation and excretion of salicylate. , 1972, American journal of veterinary research.

[60]  G. Born,et al.  Aggregation of Blood Platelets by Adenosine Diphosphate and its Reversal , 1962, Nature.